IONIS
Live / Allowed — Notice of allowance issued (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99666334
- Mark type
- Word mark
- Filed
- 23 Feb 2026
- Published for opposition
- 25 Aug 2026
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical and healthcare services; Providing medical information, healthcare information and medical information about pharmaceuticals, biologics and therapeutics; Providing healthcare and medical information regarding patient access to pharmaceuticals, biologics, and therapeutics, and safe and appropriate use and distribution of pharmaceuticals, biologics, and therapeutics; Provision of healthcare information relating to autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Healthcare services, namely, patient advisory, support and consultancy services relating to healthcare, pharmaceuticals, biologics and therapeutics; Healthcare services, namely, patient advisory, support and consultancy services regarding access to medical treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Providing medical and healthcare information in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Providing medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Collecting medical and clinical data and information on autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders for treatment and diagnostic purposes
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prior registrations
Prosecution history
- 20 Oct 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 01 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 01 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 22 Jun 2026 — ASSIGNED TO EXAMINER
- 21 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Feb 2026 — NEW APPLICATION ENTERED